Emerging market penetration has been factored into the Axon stock forecast, with projected EPS growth exceeding 20% annually, boosting investor sentiment in growth-focused portfolios. Analyst reasoning : "We're Buy-rated on Snowflake shares, supported by tailwinds such as 1) rising customer focus on data migration and modernization driven by GenAI, 2) resilient AI and data spending amid macro uncertainty, and 3) growth from new products alongside stable core consumption, enabling high-20%/30% growth in FY26/CY25E (vs consensus at 27%)." If you can stomach this volatility, Axon offers outstanding near-term and long-term upside potential. Technical charts point to strong support near $272, and Axon stock forecast models indicate potential retests of $300 within the next quarter if earnings outperform consensus estimates.